are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, even after undergoing systemic therapy, patients may have oligometastatic disease. "A lot of patients respond ...

Small cell lung cancer (SCLC) is less common, accounting for around 12% of lung cancers ... The tumour gets a high dose of radiation and the surrounding healthy tissues get a low dose, reducing the ...

"However, there is a theory called the oligometastatic theory ... later with two small tumours in his lung. Mr Anderson said: "Thanks to the trial, my cancer has been completely eradicated.

Opens in a new tab or window Affimed announced positive results of a single-arm study of 50 patients with heavily pretreated EGFR-mutated and wild-type advanced non-small cell lung cancer treated ...